Sanjay Misra

Professor

Mayo Clinic

United States

Research Interests

Explore related searches

Professors in United States Professors in Tissue Engineering Tissue Engineering professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sanjay Misra is a Professor at Mayo Clinic in the United States. His research focuses on the fields of renal interventions, pediatric vascular anomalies, and the inflammatory mechanisms associated with hemodialysis therapy. He has contributed extensively to recent literature on topics such as renal artery stenting, embolotherapy for pulmonary arteriovenous malformations, and the role of cardio-renal inflammation in arteriovenous fistula outcomes.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

UNITED STATES

View details

Ying Wang

Assistant Professor, Associate Consulant

Mayo Clinic

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sanjay Misra

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Contemporary Trends in Disparities for Renal Artery Stenting and Angioplasty in the United States

Letter to the Editor: Catheter-Based Renal Denervation to Treat Chronic Kidney Pain Secondary To Obstructive Renal Disease

Embolotherapy for Pulmonary Arteriovenous Malformations in the Pediatric Population with Hereditary Hemorrhagic Telangiectasias—A Retrospective Case Series

Perioperative Events Following Open Versus Endovascular Revascularization for Chronic Limb-Threatening Ischemia: An NSQIP Analysis

Vessel Wall Histologic Changes in a Porcine Model of Arteriovenous Fistula Stenosis Treated with Percutaneous Transluminal Angioplasty

Development of a Porcine Model of Arteriovenous Fistula Venous Stenosis Treated with Percutaneous Transluminal Angioplasty

The crosstalk between neuropilin-1 and tumor necrosis factor-α in endothelial cells

Chitosan-2D Nanomaterial-Based Scaffolds for Biomedical Applications

The Role of Cardio-Renal Inflammation in Deciding the Fate of the Arteriovenous Fistula in Haemodialysis Therapy

Racial and Ethnic Disparities in Treatment of Critical Limb Ischemia: A National Perspective

IN.PACT AV Access Randomized Trial of Drug-Coated Balloons for Dysfunctional Arteriovenous Fistulas: Clinical Outcomes Through 36 Months

Best Endovascular versus Best Surgical Therapy in Patients with CLI (BEST-CLI) Trial: A Misleading Trial Name

Neuropilin-1 deficiency in vascular smooth muscle cells is associated with hereditary hemorrhagic telangiectasia arteriovenous malformations

Bindarit encapsulated nanoparticles prevent venous neointimal hyperplasia and restenosis in a murine angioplasty model

IN.PACT AV Access Trial: Economic Evaluation of Drug-Coated Balloon Treatment for Dysfunctional Arteriovenous Fistulae Based on 12-Month Clinical Outcomes

Rationale and Trial Design of MesEnchymal Stem Cell Trial in Preventing Venous Stenosis of Hemodialysis Vascular Access Arteriovenous Fistula (MEST AVF Trial)

Novel Clinical Therapies and Technologies in Dialysis Vascular Access

Anti Human CX3CR1 VHH Molecule Attenuates Venous Neointimal Hyperplasia of Arteriovenous Fistula in Mouse Model

Periadventitial Delivery of Simvastatin‐Loaded Microparticles Attenuate Venous Neointimal Hyperplasia Associated With Arteriovenous Fistula

Collaborators (7)

Michael Torbenson

Sue Duval

Gaurav Baranwal

Randall DeMartino

Sreenivasulu Kilari

Luke Hoeppner

Ying Wang

Make your next move.